CREDIT SUISSE AG/ - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,309,975
-61.3%
87,013
-7.3%
0.00%
-62.5%
Q2 2023$8,552,742
+54.5%
93,883
+11.8%
0.01%
+33.3%
Q1 2023$5,537,210
+39.2%
83,948
+9.2%
0.01%
+50.0%
Q4 2022$3,976,912
-24.2%
76,908
+0.0%
0.00%
-33.3%
Q3 2022$5,250,000
+79.3%
76,870
+18.7%
0.01%
+100.0%
Q2 2022$2,928,000
-18.0%
64,762
-7.8%
0.00%0.0%
Q1 2022$3,570,000
+19.8%
70,266
+11.5%
0.00%
+50.0%
Q4 2021$2,980,000
+52.7%
63,032
+6.5%
0.00%
+100.0%
Q3 2021$1,951,000
-32.5%
59,187
+29.4%
0.00%
-50.0%
Q2 2021$2,890,000
+39.7%
45,728
-5.1%
0.00%
+100.0%
Q1 2021$2,069,000
-60.1%
48,208
-46.8%
0.00%
-66.7%
Q4 2020$5,181,000
+62.9%
90,570
-14.1%
0.00%
+50.0%
Q3 2020$3,181,000
-23.7%
105,422
-17.4%
0.00%
-33.3%
Q2 2020$4,168,000
+185.3%
127,599
+134.1%
0.00%
+200.0%
Q1 2020$1,461,000
-21.0%
54,516
-9.7%
0.00%0.0%
Q4 2019$1,850,000
+49.0%
60,388
+17.2%
0.00%0.0%
Q3 2019$1,242,000
+70.6%
51,540
+79.4%
0.00%0.0%
Q2 2019$728,000
+56.9%
28,725
+20.5%
0.00%
Q1 2019$464,000
+79.8%
23,840
+21.9%
0.00%
Q4 2018$258,000
+7.1%
19,556
+44.1%
0.00%
Q3 2018$241,000
-24.7%
13,569
-6.6%
0.00%
Q2 2018$320,00014,5350.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders